AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Pandriff-IV Injection

Prescription Icon
Prescription Required

Marketer

Aurista Pharma Pvt Ltd.

Salt Composition

Pantoprazole (40mg)

Overview Pandriff-IV Injection

AcidGard-IV Injection lowers stomach acid production. It treats acid-related gastrointestinal disorders like acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, relieving symptoms and promoting healing. AcidGard-IV Injection also prevents stress ulcers in critically ill patients and is used pre-anesthesia to reduce aspiration risks. A proton pump inhibitor (PPI), it's intravenously administered by a healthcare professional only when deemed superior to oral medication. Dosage depends on your condition and response; treatment duration is determined by your physician, and should be followed as prescribed even with rapid symptom relief. Optimizing treatment involves frequent, smaller meals and avoiding caffeine, spicy, and fatty foods. Common, usually mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical attention. Prolonged use, particularly over a year, may increase bone fracture risk, especially at higher doses. Discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your doctor. AcidGard-IV Injection isn't for everyone; inform your doctor of severe liver disease, HIV medication use, prior PPI allergies, osteoporosis, or pregnancy/breastfeeding before use. Avoid alcohol, which increases stomach acid, and refrain from operating machinery if dizziness or drowsiness occurs.

Uses of Pandriff-IV Injection

Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.

Major Benefits of Pandriff-IV Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Pandriff-IV Injection:

  • Diarrhea
  • Flatulence
  • Headache
  • Joint pain
  • Nausea
  • Stomach pain
  • Vomiting
  • Dizziness
  • Thrombophlebitis

How to use Pandriff-IV Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Pandriff-IV Injection works:

Gastric acid production is diminished by the proton pump inhibitor, Pandriff-IV Injection, thereby alleviating heartburn and acid indigestion.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Pandriff-IV Injection poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Pandriff-IV Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Intravenous Pandriff administration is likely safe for breastfeeding mothers. Available human data indicate minimal risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Pandriff-IV Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Pandriff-IV Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.

LiverLiverCAUTION

Administering Pandriff-IV Injection requires careful consideration in individuals with advanced hepatic impairment. Dosage modification for Pandriff-IV Injection might be necessary. Physician consultation is advised.

What if you forget to take Pandriff-IV Injection :

Omit a Pandriff-IV Injection dose? Seek your physician's advice.

Facts to Know About Pandriff-IV Injection

LabelValue
Type of Compound Benzimidazole sulfoxide compound
Potential for Dependence None.
Type of Medication Gastrointestinal system
Mechanism of Action Gastric acid secretion suppressants

FAQs on Pandriff-IV Injection

Intravenous Pandriff is indicated for managing peptic ulcers, esophageal reflux (including GERD), and the hyperacidity induced by analgesic medications. This injectable formulation also addresses Zollinger-Ellison syndrome, a condition characterized by overproduction of gastric acid. Its mechanism of action involves suppressing stomach acid secretion, thereby alleviating associated symptoms.
Concurrent use of antacids and Pandriff-IV Injection is permissible. Administer antacids at least two hours prior to, or following, Pandriff-IV Injection administration.
Improvement should be noticeable within 2 to 3 days. However, the full therapeutic effect of Pandriff-IV Injection may require up to 4 weeks, meaning some symptoms could persist until then.
Prolonged use of Pandriff-IV Injection can, in uncommon instances, lead to increased body weight. This potential side effect may be linked to improved reflux symptoms resulting in a higher food intake. Discuss any weight concerns with your physician.
Consumption of alcohol is not recommended while using Pandriff-IV Injection. While alcohol doesn't directly interfere with Pandriff-IV Injection's mechanism, it can heighten stomach acid levels, potentially exacerbating your condition.
Administering Pandriff-IV Injection is most effective one hour prior to food consumption. Dietary restrictions include the avoidance of high-fat and spicy meals during treatment. Furthermore, abstain from caffeinated beverages, including tea, coffee, and cola. Similarly, alcohol should be omitted, as it can potentially exacerbate existing symptoms.
Intravenous Pandriff is typically indicated for brief treatment periods. Nevertheless, in cases like peptic ulcer disease or Zollinger-Ellison syndrome, prolonged administration may be warranted. Extended use, however, might elevate the risk of adverse reactions and necessitates consultation with a physician. Always adhere to your doctor's instructions and remain under their medical care when using intravenous Pandriff.
Concurrent use of analgesics and Pandriff-IV Injection is considered safe. Pandrriff-IV Injection offers prophylaxis against the gastrointestinal distress, including ulcers, sometimes caused by painkiller consumption. Administer Pandriff-IV Injection one hour prior to meals; analgesics are generally best tolerated when taken with or following a meal.
A single dose of Pandriff-IV Injection may prove inadequate. Symptom relief is often achieved with just a few doses. Typically, Pandriff-IV Injection is used short-term, for up to two weeks, in cases of heartburn, indigestion, or acid reflux. Nevertheless, longer-term administration might be necessary for conditions like peptic ulcer disease and Zollinger-Ellison syndrome (ZES). If symptoms persist after two weeks of consistent use as directed, a physician's consultation is recommended.
Extended Pandriff-IV Injection use exceeding three months can trigger adverse reactions. Low blood magnesium, a primary concern, may cause fatigue, confusion, dizziness, tremors, or unsteady gait. Muscle spasms and irregular heart rhythms are also possible. Prolonged administration beyond one year elevates the risk of bone fractures, gastrointestinal infections, and vitamin B12 deficiency. This deficiency can lead to anemia, manifesting as increased fatigue, weakness, or pallor. Further symptoms might include rapid heartbeat, breathlessness, lightheadedness, digestive upset, appetite loss, flatulence, and neurological issues such as numbness, tingling sensations, and gait disturbances.
Pandriff-IV Injection
46
MRP 57
18% off